- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Exhibit 13.2
CERTIFICATIONBYTHE PRINCIPAL FINANCIAL OFFICERPURSUANTTO 18 U.S.C.
SECTION 1350,ASADOPTEDPURSUANTTO SECTION 906OFTHE SARBANES-OXLEY ACT OF 2002*
In connection with the Annual Report on Form20-F of Ascendis Pharma A/S (the “Company”) for the year ended December 31, 2019, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), the undersigned Scott T. Smith, as Chief Financial Officer and Principal Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that to the best of his knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: April 2, 2020 | ||
By: | /s/ Scott T. Smith | |
Name: | Scott T. Smith | |
Title: | Chief Financial Officer and Principal Financial Officer |